House Health Care & Wellness Committee advances multiple health bills after heated debate over public health authority

The House Health Care & Wellness Committee met in executive session Feb. 21 and voted to report out a package of health-related bills, including a substitute to House Bill 15-31 on public-health responses to communicable disease outbreaks that drew extended debate over the proper role and authority of public-health officials.

The committee voted to report the proposed substitute for House Bill 15-31 (H099.1) out of committee with a "do pass" recommendation. The substitute, which the committee discussed at length and amended unsuccessfully on multiple motions, passed the committee vote 11-7 with one member excused.

The session also reported out substitute or amended versions of bills on provider and insurer contracting (House Bill 15-89), a registry of health-care ownership and affiliations (House Bill 16-86), prosthetics and orthotics coverage (House Bill 16-69), newborn screening rules (House Bill 16-97), a certificate-of-need exemption for state-operated hospitals (House Bill 17-55) and a measure requiring plans that cover prescription hormone therapy to allow a single 12-month refill (House Bill 19-71). Votes and final tallies are listed in the "Votes at a glance" section below.

Why it matters: The most contested item, substitute House Bill 15-31, would require state and local public-health responses to communicable disease outbreaks to be guided by the best available science and evidence-based practices. Opponents warned the language could either enable mandates in future rulemaking or strip officials of authority; supporters said the substitute simply ties public-health action to science. The debate included repeated attempts to add provisions limiting emergency powers, adding business remedies, or expanding individual exemptions; committee members rejected those amendments before passing the substitute.

Key discussion points

- Public trust and scope of authority: Several members described eroded public trust in public-health agencies since the COVID-19…